Biosynth

Biosynth

Arzneimittelherstellung

Staad, St. Gallen 21.327 Follower:innen

Securing Life Sciences Supply Chains

Info

Critical Raw Materials and Services for Diagnostics, Vaccines and Pharmaceuticals. Where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. Biosynth's mission is to supply critical raw materials and services to the pharmaceutical and diagnostic industries. Biosynth strives to de-risk its customer's supply chains. Our expertise and capability runs across Complex Chemicals, Peptides and Key Biologics all from one trusted partner. Biosynth is a life sciences reagents, custom synthesis and manufacturing services company. We are by scientists, for scientists, securing supply chains with consistent quality, across the globe. We manufacture and source a vast range of chemical and biochemical products, and take pride in delivering products that others cannot. We are experts in complex chemistry, peptides and key biological raw materials. We provide a full range of products and services to support life science research and development, with more than a million products in our research catalog and hundreds of complex manufacturing service projects. The trusted supplier, manufacturer and partner for the pharmaceutical, life science and diagnostic sectors, along with customers across food, agrochemistry and cosmetics, we have facilities across three continents and a rapid global distribution network. We produce chemicals on the milligram to ton scale, and at ISO 9001 and GMP, with peptides at mg to multikilogram scale. Biosynth's services and products include enzyme development and biocatalysis, reagents for in vitro diagnostics and bioconjugation chemistry. Biosynth is owned, among others by KKR, Ampersand and Senior Management.

Website
https://www.biosynth.com
Branche
Arzneimittelherstellung
Größe
501–1.000 Beschäftigte
Hauptsitz
Staad, St. Gallen
Art
Privatunternehmen
Gegründet
1966
Spezialgebiete
Carbohydrates, Nucleosides, Enzyme substrates, Natural products, Building blocks, Biochemicals, Custom synthesis, GMP manufacturing, Large-scale manufacturing, CDMO, Diagnostics, Biochemicals, Neoantigens, Peptide libraries, cGMP, Peptides, Antibodies, Enzymes, Custom synthesis, Research products, Biologics, Epitope mapping, Life sciences, Critical Raw Materials und Sourcing

Orte

Beschäftigte von Biosynth

Updates

  • Unternehmensseite von Biosynth anzeigen, Grafik

    21.327 Follower:innen

    Improved searching, faster and simpler ordering, earning biopoints... At Biosynth, we are committed to continuous improvement, constantly enhancing our website to make it more user-friendly, ensuring that you can effortlessly explore our expanding range of products and services. Have a quick look at some of the features in our quick guide or read more at https://lnkd.in/gP57xT6Z #biosynth #customerexperience

  • Biosynth hat dies direkt geteilt

    Profil von Philip Noone anzeigen, Grafik

    Innovative CCO @ Biosynth driving new business and new product roadmap with our global lifescience customer base

    Biosynth leading the field in the earlier diagnosis of Dengue Fever virus with our increasing library of critical raw materials for emerging diseases for some of World's fastest growing diseases of concern.

    Unternehmensseite von Biosynth anzeigen, Grafik

    21.327 Follower:innen

    The lifecycle of the Dengue Virus is just another display of how viruses can invade host cells with a natural prowess. However the increasing incidence of the dengue virus is leading to a rise in global health concerns. While numerous diagnostic tests for the dengue virus are currently on the market, there are few flavivirus panel assays and no specific Dengue virus therapeutics available. Biosynth’s biologics division is leading the field in the development of target recombinant proteins and monoclonal antibodies to support the fight against infectious disease. Our range of Dengue virus proteins and antibodies provides global development teams and researchers with access to vital and new raw material to test samples, in the race to diagnose patients earlier and help with vaccine development. Our range of products features: 1) Dengue virus proteins, including envelope and NS1 from serotypes 1-4 2) Dengue virus monoclonal antibodies 3) Dengue Virus IgM ELISA kit See our list of dengue fever related products in our catalog: https://lnkd.in/dRv4_-Zb We also offer antigen design and flexible custom antibody packages. For more information visit our biologics webpage: https://lnkd.in/geJZd-a7 #denguefever #denguevirus #diagnostics #globalhealth #researchtools #innovativesolutions #biotech #viruses

  • Unternehmensseite von Biosynth anzeigen, Grafik

    21.327 Follower:innen

    GMP Peptide Manufacturing: Scientific Excellence Meets Scalability Biosynth offers comprehensive GMP peptide synthesis services, leveraging expertise in peptide chemistry and state-of-the-art facilities in the UK and Netherlands. Key features: Customizable scale: From mg to multi-kilogram batches Diverse peptide types: Diagnostic, antimicrobial, lipidated, theranostic peptides, and more Stringent QC: Comprehensive analytical testing, including MS, HPLC, AAA, and stability studies Regulatory compliance: EudraLex and ICH Q7A compliant processes End-to-end solution: Commercial supply of peptide drug substance (up to multi-kilogram scale) and fill/finish services for final drug product. Our experienced team of peptide chemists ensures optimized synthesis protocols and seamless project management. We support your drug development pipeline from preclinical to commercialization. Contact us for your GMP peptide manufacturing needs. #GMP #peptide #synthesis #drugdevelopment

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Biosynth anzeigen, Grafik

    21.327 Follower:innen

    The lifecycle of the Dengue Virus is just another display of how viruses can invade host cells with a natural prowess. However the increasing incidence of the dengue virus is leading to a rise in global health concerns. While numerous diagnostic tests for the dengue virus are currently on the market, there are few flavivirus panel assays and no specific Dengue virus therapeutics available. Biosynth’s biologics division is leading the field in the development of target recombinant proteins and monoclonal antibodies to support the fight against infectious disease. Our range of Dengue virus proteins and antibodies provides global development teams and researchers with access to vital and new raw material to test samples, in the race to diagnose patients earlier and help with vaccine development. Our range of products features: 1) Dengue virus proteins, including envelope and NS1 from serotypes 1-4 2) Dengue virus monoclonal antibodies 3) Dengue Virus IgM ELISA kit See our list of dengue fever related products in our catalog: https://lnkd.in/dRv4_-Zb We also offer antigen design and flexible custom antibody packages. For more information visit our biologics webpage: https://lnkd.in/geJZd-a7 #denguefever #denguevirus #diagnostics #globalhealth #researchtools #innovativesolutions #biotech #viruses

  • Unternehmensseite von Biosynth anzeigen, Grafik

    21.327 Follower:innen

    Gangliosides are widely distributed in different tissues. They are particularly abundant in neuronal cells and play essential roles in maintaining cell membrane integrity and signaling. More so - they are a key part of the virulence of a number of diseases, including botulism and tetanus. Read more in our blog: Toxins and Gangliosides: A Complex Interaction. ➡ https://lnkd.in/ekNhj2HA #toxin #biosynth #gangliosides

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Biosynth anzeigen, Grafik

    21.327 Follower:innen

    Showing remarkable capabilities of degrading 'more than one million molecules of hydrogen peroxide a second' (Kaushal, 2018), the enzyme catalase demonstrates its environmentally friendly, industrial prowess. It has successful application in bioremediation, textiles, paper, food, and pharmaceutical industries and is an intriguing solution to environmental monitoring in sterile facilities, hampered by traces of hydrogen peroxide disinfectant. For this latter application, Biosynth has developed a powerful catalase enzyme called ECAT01TM with an innovative patented application, available to purchase from our research product catalog (EC179336). https://lnkd.in/e2zVn88v If you are a contact plate manufacturer or need to confirm the sterility of your laboratory under regulations, Biosynth recommends the addition of our catalase ECAT01TM into your growth media. This proprietary, potent, and stable enzyme gives you rapid and reliable confirmation that your surfaces and equipment are sterile. Read our blog to discover more about these intriguing enzymes making our industrial processes more sustainable and enabling environmental monitoring in labs to be safer and more effective.  https://lnkd.in/ek6y6CUt #catalase #enzymes #environmentalmonitoring #sterilitytesting #sustainability #environmentallyfriendly

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von Biosynth anzeigen, Grafik

    21.327 Follower:innen

    Do you know what day is today? It is World Chocolate Day, a global celebration of this iconic treat. At Biosynth, we love science, but even we can't resist indulging in a fun fact – especially when it involves chocolate! We do not intend to promote the (over) consumption of chocolate. As scientists, we want to delve into the fascinating science behind your (most probably) favorite treat chocolate, and the complex blend of chemicals that create that smooth texture, rich aroma, and of course, the irresistible taste we all know and love. Sit back, read, consume, digest the content, and enjoy…. perhaps with a piece of your favorite chocolate. After all, a little indulgence paired with a dash of knowledge is a recipe for pure enjoyment! #worldchocolateday #funscience #sciencefact #biosynth

  • Unternehmensseite von Biosynth anzeigen, Grafik

    21.327 Follower:innen

    It may be that the next coming years are our last chance to save our planet. However the hopes of a green future are becoming ever more attainable. Researchers are working tirelessly to develop novel technologies to defend our planet, while striking a balance with modern living and consumerism. Enzymes are such an audacious technology willing to offer us a lifeline in their potential to decrease CO2 emissions, reduce the carbon demand associated with chemical synthesis, reduce chemical usage and decrease the economic losses associated with global warming. Using enzymatic solutions will help against climate change significantly and will even be of benefit to the health of the planet and its biodiversity. Biosynth is proud to support green chemistry and work with customers looking to work sustainably. We have expanded our enzyme repertoire to provide sustainable enzyme products and solutions for industrial applications and offer the development of customized enzyme and biocatalysis solutions for your target application. Visit our enzyme webpage for more information on our smart enzyme solutions and biocatalysis services. https://lnkd.in/eqcmJH52 Read our slider below delving into the desperate need for a solution to climate change and how enzymes can achieve this. #enzymes #enzymesolutions #biocatalysis #greenchemistry #climatechange #globalwarming #sustainability

  • Unternehmensseite von Biosynth anzeigen, Grafik

    21.327 Follower:innen

    Exosomes are perfect candidates to monitor disease, primarily because they are present in a variety of biological fluids, are released from all cells, and contain important information regarding the state of their parent cells. However many assay formats require exosomes to be isolated. Isolating exosomes from biological fluids has been a challenge in the past and while isolation processes such as ultracentrifugation have been considered the gold standard, they too have disadvantages as the high levels of force used can mechanically damage the integrity of exosomes. That is why Biosynth offer our customers a novel and specific exosome capture method that uses the Vn96 (US Patent # 8,956,878) https://lnkd.in/ekkVX3GY peptide reagent that binds to canonical HSPs found on the surface of exosomes. Vn96 isolation produces results comparable to ultracentrifugation, but at much great efficiency as 1/30th of the sample size is required. We have two kits available to purchase online based on optimization of how different sample types behave. Order yours today The ME™ Kit (urine/media), patent US 8,956,878: https://lnkd.in/eMs6hJsX The ME™ Kit (plasma), patent US 8,956,878: https://lnkd.in/e7iXkCM5 Read our article below to find out about how exosomes are made and their diagnostic and therapeutic potential. #exosomes #exosomeisolation #innovation #diagnostics #therapeutics #lifesciences

    The Art of the Exosome

    The Art of the Exosome

    Biosynth auf LinkedIn

Ähnliche Seiten